<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Internal (formerly female) condoms</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Internal (formerly female) condoms</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Internal (formerly female) condoms</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Theresa Hoke, PhD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Katherine M Stone, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Markus J Steiner, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Lee Warner, PhD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Courtney A Schreiber, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen Eckler, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 17, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The internal (formerly female) condom provides a physical barrier between genitalia and secretions during intercourse. It is designed to protect against both pregnancy and sexually transmitted infections. The internal condom consists of an outer ring attached to a sheath that lines the vagina, and an inner ring or sponge that covers the cervix. The internal condom provides coital-dependent reversible contraception that does not interfere with fertility and is available without prescription.</p><p>This topic will review the structure, patient counseling, and use of internal condoms, specifically the FC2. Similar information on external (formerly male) condoms and general information on contraceptive counseling and selection are presented separately. </p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5463.html" rel="external">"External (formerly male) condoms"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5459.html" rel="external">"Contraception: Counseling and selection"</a>.)</p><p></p><p>In this topic, when discussing study results, we will use the terms "woman/en" or "patient(s)" as they are used in the studies presented. However, we encourage the reader to consider the specific counseling and treatment needs of transmasculine and gender-expansive individuals.</p><p class="headingAnchor" id="H2"><span class="h1">TYPES OF INTERNAL CONDOMS</span></p><p class="headingAnchor" id="H2940016636"><span class="h2">Common structure</span><span class="headingEndMark"> — </span>Internal condoms have an anchor (eg, ring, frame) outside of the vagina to prevent the condom from being pushed inside the vagina during use; the anchor is also used for removing the condom. The inner portion consists of a sheath that lines the vagina. Some internal condoms also have an inner ring  (<a class="graphic graphic_picture graphicRef59955" href="/z/d/graphic/59955.html" rel="external">picture 1</a>) or sponge that lies against the cervix. Internal condoms have been made out of natural rubber latex, nitrile (a synthetic latex), and polyurethane [<a href="#rid1">1</a>]. They prevent pre-ejaculatory fluid and semen from entering the user's vagina and thus theoretically should prevent both pregnancy and the spread of sexually transmitted infections (STIs). No spermicide is required, but a lubricant is often needed. An illustration can be seen at the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fmedlineplus.gov%2Fency%2Fimagepages%2F17063.htm&amp;token=d5ngiCbB8xFYJWkFI1xceqAGzPvynFygK1nfgUuThTwljP0HkSIH9hDKz28mfMhcWze07WABX2nX3iK3gDNTTw%3D%3D&amp;TOPIC_ID=5471" target="_blank">US National Library of Medicine</a>. Internal condoms account for less than 1 percent of condoms produced globally [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H567772073"><span class="h2">FC2 and FC1 devices</span><span class="headingEndMark"> — </span>The most widely available internal condom is FC2 [<a href="#rid3">3</a>]. It is a soft, loose-fitting nitrile sheath or pouch with two flexible rings. One ring is contained within the closed end of the sheath and serves as an insertion mechanism and internal anchor that lies against the cervix. The other ring forms the external, open edge of the device; it remains outside of the vagina after insertion. Silicone-based lubricant lines the inside of the condom, but additional lubrication for the inside and/or outside could be used. The condom is approximately 17 cm (6.5 inches) in length (similar to an external condom).</p><p>In contrast to the FC2, the previously marketed FC1 was made of polyurethane and had a seam. In comparative trials, the FC2 performed as well as the FC1 in terms of patient satisfaction, breakage, slippage, and invagination (ie, when the outer ring of the condom pushes into the vagina during intercourse) [<a href="#rid4">4,5</a>]. No data on pregnancy prevention or STI prevention are available for FC2 specifically, but effectiveness is assumed to be similar to the FC1 given the similar design, specifications, and functionality. (See <a class="local">'Efficacy'</a> below.)</p><p>The FC2 is indicated for preventing pregnancy and transmission of HIV and other STIs [<a href="#rid6">6</a>]. It may make less noise during intercourse than the FC1 and is available in approximately 100 countries. It has been approved by the US Food and Drug Administration (FDA); has CE Marking, which certifies that the device meets consumer safety standards and can be marketed in countries in the European Union; and has been cleared by the World Health Organization (WHO) for purchase by United Nations agencies.</p><p class="headingAnchor" id="H1229187477"><span class="h2">Other devices</span><span class="headingEndMark"> — </span>Variations to the FC1/FC2 have been developed. One randomized crossover trial examining condom failure events (eg, breakage, slippage, and invagination) reported similar outcomes for the following three devices versus the FC2 [<a href="#rid7">7</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Natural Latex Female Condom (commercial name: Cupid Angel)</strong> – The Natural Latex Female Condom has received WHO approval and is distributed in India, Brazil, Indonesia, Netherlands, South Africa, and Mozambique [<a href="#rid8">8,9</a>]. In a noninferiority crossover trial including 300 female participants, the clinical failure rate (clinical breakage and slippage, invagination, misdirection [the penis slipping between the vagina and the outer surface of the condom]) was similar for the Cupid2 and FC2 [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Program for Appropriate Technology in Health Woman's Condom (PATH WC)</strong> – The PATH WC is made of polyurethane and placed using an insertion capsule, which dissolves after insertion and releases the condom [<a href="#rid11">11</a>]. Hydrophilic areas on the condom allow it to cling lightly to the vaginal wall and keep it in place. It is not prelubricated but is sold with a water-based lubricant [<a href="#rid12">12</a>]. The WC was granted CE Marking in 2010 and the South African Bureau of Standards certification mark in 2013. To support market registration in China, a single-arm use study was conducted to assess WC performance and safety. The study reported levels of functionality consistent with condom performance data from other internal condoms [<a href="#rid13">13</a>]. In 2016, the product was cleared by WHO for purchase by United Nations agencies [<a href="#rid14">14</a>]. Following that approval, the WC had been made available through donor-supported programs to expand contraceptive options in some sub-Saharan African countries.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>VA w.o.w</strong> (worn of women; sample brand names: Condom Feminine, L'amour female condom, Reddy FC) – The VA w.o.w is made of natural rubber latex and is available in some parts of Europe, Asia, and Latin America. It has been granted CE Marking and India Drug Control Authority approval. The condom has a medical-grade sponge at one end that is used for insertion; the other end has a triangular frame to anchor it outside of the vagina. It is prelubricated [<a href="#rid12">12</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Phoenurse </strong>– The polyurethane Phoenurse is distributed in China [<a href="#rid15">15</a>]. A randomized crossover trial conducted in China showed that breakage, slippage, and misdirection of the penis were significantly more common with the Phoenurse than with the FC2 [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Natural Sensation Panty Condom</strong> – The Natural Sensation Panty Condom, consisting of a woman's panty with a replaceable condom made of polyethylene resin, is available in parts of Europe and South America [<a href="#rid12">12</a>].</p><p></p><p class="headingAnchor" id="H752784159"><span class="h1">COUNSELING POINTS</span></p><p class="headingAnchor" id="H3868154701"><span class="h2">Mechanism</span><span class="headingEndMark"> — </span>All internal condoms provide a physical barrier that prevents pre-ejaculatory fluid and semen from entering the female reproductive tract. Internal condoms must be used correctly with every act of vaginal intercourse to be effective at preventing pregnancy and sexually transmitted infection (STI) transmission.</p><p class="headingAnchor" id="H3"><span class="h2">Efficacy</span></p><p class="headingAnchor" id="H4"><span class="h3">Pregnancy prevention</span><span class="headingEndMark"> — </span>The most rigorous data regarding contraceptive effectiveness of internal condoms were derived from a cohort study of 221 couples using the FC1 (Reality) internal condom [<a href="#rid17">17</a>]. The estimated rates of pregnancy during the first 12 months of perfect use and typical use were 5 and 21 percent, respectively; these pregnancy rates are higher than those associated with use of external condoms (perfect and typical use pregnancy rates of 2 and 13 percent, respectively  (<a class="graphic graphic_table graphicRef120134" href="/z/d/graphic/120134.html" rel="external">table 1</a>) [<a href="#rid1">1,18</a>]). While other less rigorous studies conducted with FC1 [<a href="#rid19">19-21</a>] suggested lower pregnancy rates with use of internal condoms, we use the rates presented above when counseling patients [<a href="#rid21">21</a>]. The effectiveness of the FC2 is assumed to be similar to that of the FC1, given its similar design, specifications, and functionality [<a href="#rid4">4,5</a>].</p><p class="headingAnchor" id="H5"><span class="h3">Sexually transmitted infections</span><span class="headingEndMark"> — </span>A small number of laboratory and clinical studies suggest that internal condoms help to protect against transmission of STIs, but data are much more limited than for external condoms [<a href="#rid22">22-30</a>]. (See  <a class="medical medical_review" href="/z/d/html/5463.html" rel="external">"External (formerly male) condoms"</a>.) </p><p>In vitro data suggest the internal condom may provide an impermeable barrier to HIV and cytomegalovirus, as well as other STIs [<a href="#rid23">23,24</a>], but no clinical studies have specifically evaluated the internal condom's ability to prevent HIV transmission. Two of three randomized trials of behavioral interventions to promote use of the internal condom observed that groups assigned to use FC1 had lower STI rates than groups assigned to use external condoms, but the differences were not statistically significant [<a href="#rid26">26,27</a>]. In the third trial, the STI rate in the group who only had access to external condoms was the same as that for the group with access to both external and internal condoms [<a href="#rid29">29</a>]. (See  <a class="medical medical_review" href="/z/d/html/7595.html" rel="external">"Prevention of sexually transmitted infections"</a>.)</p><p>By contrast, an observational study provided evidence that adding internal condoms (FC1) to an external condom distribution program targeting sex workers significantly increased the proportion of protected sex acts and significantly reduced STI prevalence [<a href="#rid28">28</a>].</p><p class="headingAnchor" id="H6"><span class="h2">Why choose internal condoms?</span></p><p class="headingAnchor" id="H7"><span class="h3">General advantages</span><span class="headingEndMark"> — </span>The internal condom offers several contraceptive and noncontraceptive benefits to users:</p><p class="bulletIndent1"><span class="glyph">●</span>Safe, effective, reversible method of contraception with no delay in return of fertility following discontinuation of the method.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Can be obtained without a medical examination, prescription, or special fitting.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Minimal side effects since it is relatively inert and the body is exposed to it only in anticipation of coitus and not at other times.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Provides protection against STIs and offers an option to users whose sexual partners cannot or will not use an external condom. It offers broader coverage of external genitalia than the external condom and thus may give better coverage against STIs transmitted via skin lesions or shedding. (See <a class="local">'Sexually transmitted infections'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>May stimulate the clitoris with the external ring, thus enhancing sexual arousal [<a href="#rid31">31</a>].</p><p></p><p class="headingAnchor" id="H8"><span class="h3">General disadvantages</span><span class="headingEndMark"> — </span>The only contraindication to internal condom use is allergy to nitrile. Fortunately, most people with latex allergies can still use nitrile products. (See  <a class="medical medical_review" href="/z/d/html/13656.html" rel="external">"Common allergens in allergic contact dermatitis", section on 'Rubber accelerators'</a> and  <a class="medical medical_review" href="/z/d/html/5543.html" rel="external">"Latex allergy: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p>However, internal condoms do have some disadvantages that may lead to inconsistent, incorrect, or nonuse, including:</p><p class="bulletIndent1"><span class="glyph">●</span>Some users find it difficult to insert and remove.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The outer ring is visible outside of the vagina, which can be unacceptable to users or their sexual partners.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>It has a higher failure rate in preventing pregnancy compared with most other female contraceptive methods and the external condom  (<a class="graphic graphic_figure graphicRef119765" href="/z/d/graphic/119765.html" rel="external">figure 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>It can make noise during intercourse.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Some patients feel embarrassed or uncomfortable when obtaining condoms or suggesting use of condoms.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Internal condoms are not as widely available as external condoms. </p><p></p><p class="headingAnchor" id="H2280902285"><span class="h3">Comparison of coital-dependent methods</span><span class="headingEndMark"> — </span>Patients who desire contraception that is used only at the time of intercourse can choose among external condoms, internal condoms, diaphragms, cervical caps, contraceptive sponges, and spermicide. The typical-use pregnancy rates range from 12 percent (diaphragm) to over 20 percent (internal condom, contraceptive sponge, spermicide) for the group  (<a class="graphic graphic_figure graphicRef119765" href="/z/d/graphic/119765.html" rel="external">figure 1</a>). </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Comparison with external condoms</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Internal condoms can be placed before intercourse, do not require an erect penis, and can be removed any time after ejaculation, so they are potentially less disruptive of intimacy. (See <a class="local">'Patient instructions'</a> below.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>External condoms are usually made of latex while internal condoms are usually made of synthetic materials (nitrile, polyurethane), which do not have special storage requirements, can be used with both oil- and water-based lubricants, are unlikely to cause allergic reaction, and are stronger than latex. (See  <a class="medical medical_review" href="/z/d/html/5463.html" rel="external">"External (formerly male) condoms"</a>.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Internal condoms are more expensive than external condoms (approximately USD $6 to $7 versus less than USD $1) but may be available for free or at a reduced cost through family planning programs [<a href="#rid32">32-35</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The internal condom is a vaginal device. Unlike the external condom, it is not recommended for anal sex due to reported problems with use and sparse evidence about clinical effectiveness [<a href="#rid36">36</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In contrast with external condoms, internal condoms are not tight. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>No published randomized trials have compared the clinical effectiveness of external and internal condoms for prevention of either pregnancy or STIs (including HIV). However, two randomized crossover trials of internal and external condoms in the United States and Brazil used proxy measures of breakage, slippage, and prostate-specific antigen (PSA) as indicators of semen exposure [<a href="#rid37">37,38</a>]. Participants used both condom types, completed condom-specific questionnaires to report problems, and collected precoital and postcoital samples of vaginal fluid for PSA. Although PSA detection rates were similar for both internal and external condoms, users in both trials reported internal condoms were associated with significantly more mechanical problems (eg, slippage, breakage, misdirection of the penis) than external condoms [<a href="#rid39">39</a>]. Regardless of the type of internal condom, difficulties with use, such as slippage and invagination, decrease with experience: markedly so after as few as five uses [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Comparison with diaphragms and cervical caps</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Unlike the internal condom, diaphragms and cervical caps are contained completely within the vagina and are therefore not visible to users or their sexual partners. All three devices need to be inserted prior to any vaginal sexual activity. Internal condoms can be removed immediately after intercourse, while diaphragms and caps should remain in place for at least six hours after the last act of intercourse. (See  <a class="medical medical_review" href="/z/d/html/3265.html" rel="external">"Pericoital (on demand) contraception: Diaphragm, cervical cap, spermicides, and sponge"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Similar to the internal condom, the single-size silicone diaphragm does not require a medical examination, fits most female patients, does not interfere with fertility, and is used on-demand. The diaphragm requires use of a separate spermicide, which also makes it more effective at preventing pregnancy than the internal condom (typical use pregnancy rate of 12 versus 21 percent). However, only the internal condom can provide protection against STIs. (See  <a class="medical medical_review" href="/z/d/html/3265.html" rel="external">"Pericoital (on demand) contraception: Diaphragm, cervical cap, spermicides, and sponge", section on 'Single size'</a>.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In contrast to the internal condom, the cervical cap requires a medical examination for proper fitting, needs to be resized after pregnancy, and requires separate spermicide application with every use. The risk of unintended pregnancy is similar for the two methods, but only the internal condom protects against STIs. (See  <a class="medical medical_review" href="/z/d/html/3265.html" rel="external">"Pericoital (on demand) contraception: Diaphragm, cervical cap, spermicides, and sponge", section on 'Cervical cap'</a>.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Unlike the single-size diaphragm and cervical cap, the internal condom is not intended to be reused. (See <a class="local">'Reuse'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Comparison with spermicides and contraceptive sponge</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The internal condom, spermicide, and contraceptive sponge all provide over-the-counter, on-demand protection against pregnancy and do not require a medical examination. First-year typical-use failure rates exceed 20 percent for all three methods  (<a class="graphic graphic_figure graphicRef119765" href="/z/d/graphic/119765.html" rel="external">figure 1</a>). Only the internal condom definitively provide protection against STIs. (See  <a class="medical medical_review" href="/z/d/html/3265.html" rel="external">"Pericoital (on demand) contraception: Diaphragm, cervical cap, spermicides, and sponge", section on 'Vaginal spermicide and pH regulator gel'</a> and  <a class="medical medical_review" href="/z/d/html/3265.html" rel="external">"Pericoital (on demand) contraception: Diaphragm, cervical cap, spermicides, and sponge", section on 'Spermicidal contraceptive sponge'</a>.)</p><p></p><p class="headingAnchor" id="H326257222"><span class="h2">Strategies for promoting effective internal condom use</span><span class="headingEndMark"> — </span>The optimal methods of counseling to ensure correct and consistent internal condom use are not known. The World Health Organization (WHO) advises the following steps to support patients who wishes to use internal condoms [<a href="#rid1">1</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ensure correct understanding of use</strong> – Once the instructions for internal condom use have been explained, ask the patient to repeat back the five basic steps (see <a class="local">'Patient instructions'</a> below). Ideally, a plastic model of the female pelvis can be used to practice insertion and removal.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Explain the importance of properly</strong> <strong>using a condom with every sex act</strong> – As with all contraceptives, internal condoms are most effective when used correctly and consistently with every episode of vaginal intercourse. Educate patients that one sex act can lead to unintended pregnancy and/or an STI, including HIV infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Review ways to discuss condom use and troubleshoot anticipated problems</strong> – Internal condom use requires partner cooperation, but not all people are comfortable discussing condom use. Encourage patients to bring up their plan for internal condom use before intercourse to improve the odds that a condom is used and that it is used correctly. The patient and their sexual partner(s) may benefit from counseling. This conversation allows the clinician, patient, and partner to address any questions or concerns.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Supply internal condoms or provide access information</strong> – Ideally, patients are sent home with a supply of internal condoms for both practice and use. New users may benefit from trial insertion (ie, insertion before intercourse is anticipated) and removal. If they are unavailable, discuss where internal condoms can be purchased (eg, local retail pharmacies and online sites). Encourage the patient to keep a supply of internal condoms in case one breaks or becomes damaged.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Encourage the patient and/or sexual partner(s) to come back anytime</strong> – Advise patients that they, along with their sexual partner, are welcome to return anytime to discuss problems, questions, or concerns with this method.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Inform patients about limitations </strong>– Advise them that, compared with external condoms and intrauterine and hormonal methods, information on efficacy is limited and that internal condoms may be difficult to buy.</p><p></p><p class="headingAnchor" id="H11"><span class="h1">INFORMATION FOR INTERNAL CONDOM USE</span></p><p class="headingAnchor" id="H854689396"><span class="h2">Patient instructions</span><span class="headingEndMark"> — </span>The basic steps of internal condom use below are reviewed with the patient and partner, if present  (<a class="graphic graphic_figure graphicRef118415" href="/z/d/graphic/118415.html" rel="external">figure 2</a>). A free interactive FC2 training program is available for health care providers <a class="external" href="/external-redirect?target_url=https%3A%2F%2Ffc2femalecondom.com%2Fhow-to-use%2F&amp;token=MG4%2B3yhfwIpfLri6gbO0hztsylmyG0mxVS6bVy5kpwjGu20MZhH28Q9nobrOEGFW&amp;TOPIC_ID=5471" target="_blank">online</a>. FC2 can be purchased online or from retail pharmacies. It is also available from some state and municipal health agencies and nonprofit organizations.</p><p class="bulletIndent1"><span class="glyph">●</span>A new internal condom should be used with every act of vaginal intercourse. The internal condom should not be used concurrently with an external condom since friction between the two condoms may cause breakage.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The user can assume any position that is comfortable for inserting the internal condom. It can be inserted up to eight hours before intercourse. Before insertion, the user should make sure the condom is adequately lubricated for passage through the vagina, which will also minimize noise during sex. Either water-based or oil-based lubricants can be used.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The inner ring at the closed end of the FC2 is squeezed with the thumb and middle finger, as with a diaphragm, and then inserted into the vaginal opening. The index finger is then placed inside the condom and used to push the inner ring as far into the vagina as it will go, without allowing the condom to twist. The outer ring remains outside the vagina and extends approximately 1 inch beyond the labia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>At intromission, it is important to ensure that the penis does not slip between the vagina and the outer surface of the condom. It may be helpful for the partner to guide penis insertion into the ring. During intercourse, it is important to ensure that the outer ring does not get pushed into the vagina. The internal condom can be used during menses and for any position of vaginal intercourse. (See <a class="local">'Use with lubricants and/or medications'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The internal condom can be removed any time after intercourse. It should be taken out before the user stands up to avoid having the semen spill out. The outer ring of the condom is twisted (clockwise or counterclockwise) to seal the condom, and then pulled out and wrapped in the package it came in and/or in a tissue. It should be disposed of in waste containers, not in the toilet. The internal condom cannot migrate into a patient's uterus or body. </p><p></p><p class="headingAnchor" id="H12"><span class="h2">Reuse</span><span class="headingEndMark"> — </span>Internal condoms, including the FC2, are not recommended for reuse since this approach has not been studied [<a href="#rid1">1</a>]. However, use of a new device with every act of intercourse may be difficult because of problems with cost or access. Limited data support disinfecting protocols for reuse of the FC1 condom [<a href="#rid41">41-43</a>]. Thus, for users with limited access to condoms and contraceptive methods, a program of washing, disinfecting, and reusing internal condoms may be preferable to having unprotected intercourse, although the efficacy of reused internal condoms is unknown.</p><p class="headingAnchor" id="H102545565"><span class="h2">Complications or failure</span><span class="headingEndMark"> — </span>The main complications are penis insertion to the side of the condom, invagination (ie, when the outer frame of the condom pushes into the vagina during intercourse), and condom breakage. To help avoid misdirection of the penis, it may be helpful for the partner to guide the tip of the penis into the center of the external condom ring. Invagination can be minimized by using one hand on the outer ring to hold it in place. Should invagination occur, the outer ring is pulled out of the vagina and seated back into proper location. Breakage can be minimized by using a new condom with every act of vaginal intercourse and using adequate lubrication. (See <a class="local">'Use with lubricants and/or medications'</a> below.) </p><p class="headingAnchor" id="H1198192481"><span class="h2">Use with lubricants and/or medications</span><span class="headingEndMark"> — </span>In contrast with latex external condoms, the FC2 can be used with both water- or oil-based lubricants because it is made of nitrile, a synthetic latex (rubber). Commonly available products that can be used as lubricants for non-latex internal condoms include saliva, clean water, butter, and cooking oils.</p><p class="headingAnchor" id="H3783212852"><span class="h2">Storage and expiration</span><span class="headingEndMark"> — </span>Most available internal condoms are made of synthetic materials (nitrile, polyurethane) and do not have special storage requirements. The product should be used before the manufacturer's expiration date.</p><p class="headingAnchor" id="H346452001"><span class="h1">RESOURCES FOR PATIENTS AND CLINICIANS</span><span class="headingEndMark"> — </span>Additional information about internal condoms and other contraceptive options can be found at the following sites:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=http%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2Fhandle%2F10665%2F260156%2F9780999203705-eng.pdf&amp;token=IpGOqtoMcjkeqLlStmIYc46%2FESB13qM58veMlHOf0J5Ll50ZKasdU982W98Vf9kkhxSNzcDLXLmSRs8RW10rVFQGyIEyNaPfWBqe%2Bi8aiWM%3D&amp;TOPIC_ID=5471" target="_blank">World Health Organization Family Planning Global Handbook for Providers</a> (2018)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.plannedparenthood.org%2F&amp;token=xXI%2By9QNEPjV52%2B%2BDeHAeZ9SXc2ukqt22nAmmnoIhbmjKCcbIKeiWKTXDj94bQ%2F4&amp;TOPIC_ID=5471" target="_blank">Planned Parenthood</a> – A nonprofit organization dedicated to reproductive health with resources for patients and clinicians.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.bedsider.org%2F&amp;token=h7Ird6MEQJ0ciS3wlIS74wS%2BbqJQEspyaSo36FRNdkGJJnrJaPDlUEGuXmILPu5F&amp;TOPIC_ID=5471" target="_blank">bedsider.org</a> – A free website developed by the National Campaign to Prevent Teen and Unplanned Pregnancy, a private nonprofit group.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.choiceproject.wustl.edu%2F&amp;token=%2BnVJmPhZ7CoZ6P5TTscsQMEfRjhRSH%2BHYjLFHmNv8MpZBNOY80TFEfWmQJ4v5GVF&amp;TOPIC_ID=5471" target="_blank">CHOICE Project</a> – A free website sponsored by the Washington University School of Medicine in St. Louis that provides resources on contraceptive options and training resources for clinicians.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fyoungwomenshealth.org%2F&amp;token=9SOQ31M5muHbxxUii9uduj7uOdQP%2BNVKJGoE4M4lyiOJKXEoosD%2FJno5DMXZnUfG&amp;TOPIC_ID=5471" target="_blank">Center for Young Women's Health</a> – A free website run by Boston Children's Hospital that addresses the reproductive health needs of teens and young adults.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fbeyondthepill.ucsf.edu%2F&amp;token=fttfTRGBi4dPw6uXwXDlebLq6gqwpTXS04i8%2BZvnWbO91%2Bn%2BSCxS3t417U%2FzXuYs&amp;TOPIC_ID=5471" target="_blank">Beyond the Pill</a> – A free website run by the University of California San Francisco.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.sexandu.ca%2F&amp;token=vdCs7dqmABYrTYLl86e3UBvZDVaCgDBYOgHXgKrHwtk%3D&amp;TOPIC_ID=5471" target="_blank">Sex &amp; U</a> – An educational site run by the Society of Obstetricians and Gynaecologists of Canada that includes descriptions of various methods and a tool to help with selection of birth control.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.acog.org%2Fwomens-health%3Futm_source%3Dvanity%26utm_medium%3Dweb%26utm_campaign%3Dforpatients&amp;token=qUmAumKxYlR4%2FWhFIO617bbVPryzK45FVMORpzd0eTkOHwEODrFxaxEQA6GI%2BtyWhu%2Bvv3Wjn6tp28Uu29iw8YaBltZkt0fvpqXlraqEdtKXaUrHwQurQk4SBR4%2B1XML&amp;TOPIC_ID=5471" target="_blank">American College of Obstetricians and Gynecologists (ACOG) Contraceptive FAQs</a> – ACOG addresses frequently asked questions (FAQs) about contraception.</p><p></p><p class="headingAnchor" id="H3614373043"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/112268.html" rel="external">"Society guideline links: Contraception"</a>.)</p><p class="headingAnchor" id="H13"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/132033.html" rel="external">"Patient education: Barrier methods of birth control (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/8422.html" rel="external">"Patient education: Barrier and pericoital methods of birth control (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H14"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Internal (formerly female) condoms consist of an anchor (eg, ring, frame) that sits outside of the vagina, a sleeve that lines the vagina, and often an inner ring or sponge that holds the device in place. Internal condoms are commonly made out of nitrile (a synthetic latex) but have also been made out of natural rubber latex and polyurethane. The FC2 condom is the most commonly available internal condom globally. (See <a class="local">'Types of internal condoms'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The internal condom provides a physical barrier that prevents pre-ejaculatory fluid and semen from entering the female reproductive tract. Internal condoms must be used correctly with every act of vaginal intercourse to be effective at preventing pregnancy and sexually transmitted infection (STI) transmission. (See <a class="local">'Mechanism'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The best estimates for the rates of unintended pregnancy during the first 12 months of perfect use and typical use of the FC2 internal condom are 5 and 21 percent, respectively; these rates are higher than those associated with use of the external (formerly male) condom (perfect- and typical-use pregnancy rates of 2 and 13 percent, respectively). Use of internal condoms can also provide protection from acquisition and transmission of STIs, although data are very limited. (See <a class="local">'Efficacy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Internal condoms are a safe, effective, reversible method of contraception that does not delay return of fertility. They can be obtained without a medical examination, prescription, or special fitting. Internal condoms are an option for patients who could be exposed to STIs when the sexual partner cannot or will not use an external condom. (See <a class="local">'General advantages'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The only contraindication to internal condom use is allergy to nitrile. Most people with latex allergies can still use nitrile products. Other disadvantages can include problems with insertion or removal. (See <a class="local">'General disadvantages'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The internal condom offers several advantages over the external condom (eg, it can be placed before intercourse, does not need to be removed immediately after ejaculation), as well as some disadvantages (eg, it is more expensive and should not be used for anal intercourse). Compared with the diaphragm and cervical cap, the internal condom should provide better protection against acquisition and transmission of STIs. (See <a class="local">'Comparison of coital-dependent methods'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A new internal condom should be used with every act of vaginal intercourse but not concurrently with an external condom. It can be inserted into the vagina up to eight hours before intercourse. Unlike external condoms, either water-based or oil-based lubricants can be used with internal condoms. (See <a class="local">'Patient instructions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Internal condoms, including the FC2, are not recommended for reuse since this approach has not been studied. (See <a class="local">'Reuse'</a> above.) </p><p></p><p class="headingAnchor" id="H13705431"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Willard Cates, Jr, MD, MPH, who contributed to an earlier version of this topic review.</p><p>The findings and conclusions in this topic review are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention (CDC).</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Family Planning: A Global Handbook for Providers (2018 update), World Health Organization Department of Reproductive Health and Research (WHO/RHR), Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP), Knowledge for Health Project (Eds), CCP and WHO, Baltimore and Geneva 2018. p.261-270.</li><li class="breakAll">Center for Health and Gender Equity. Saving lives now: Female condoms and the role of US foreign aid. Takoma Park, MD, 2008.</li><li class="breakAll">fc2 Female Condom. Veru Inc. 2018. http://www.fc2femalecondom.com (Accessed on July 13, 2018).</li><li><a class="nounderline abstract_t">Smit J, Beksinska M, Vijayakumar G, Mabude Z. Short-term acceptability of the Reality polyurethane female condom and a synthetic latex prototype: a randomized crossover trial among South African women. Contraception 2006; 73:394.</a></li><li><a class="nounderline abstract_t">Beksinska M, Smit J, Mabude Z, et al. Performance of the Reality polyurethane female condom and a synthetic latex prototype: a randomized crossover trial among South African women. Contraception 2006; 73:386.</a></li><li><a class="nounderline abstract_t">Second generation of female condom receives FDA committee approval. Contraceptive Technology Update 2009; 30:25.</a></li><li><a class="nounderline abstract_t">Beksinska ME, Piaggio G, Smit JA, et al. Performance and safety of the second-generation female condom (FC2) versus the Woman's, the VA worn-of-women, and the Cupid female condoms: a randomised controlled non-inferiority crossover trial. Lancet Glob Health 2013; 1:e146.</a></li><li><a class="nounderline abstract_t">Beksinska M, Smit J, Joanis C, Potter W. New female condoms in the pipeline. Reprod Health Matters 2012; 20:188.</a></li><li class="breakAll">Cupid Angel Female Condoms. Cupid Limited. http://www.cupidlimited.com/female-condoms/#.W0jbdtUzpFE (Accessed on July 13, 2018).</li><li><a class="nounderline abstract_t">Beksinska M, Greener R, Kleinschmidt I, et al. A randomized noninferiority crossover controlled trial of the functional performance and safety of new female condoms: an evaluation of the Velvet, Cupid2, and FC2. Contraception 2015; 92:261.</a></li><li><a class="nounderline abstract_t">Schwartz JL, Barnhart K, Creinin MD, et al. Comparative crossover study of the PATH Woman's Condom and the FC Female Condom. Contraception 2008; 78:465.</a></li><li><a class="nounderline abstract_t">Beksinska M, Smit J, Joanis C, et al. Female condom technology: new products and regulatory issues. Contraception 2011; 83:316.</a></li><li><a class="nounderline abstract_t">Zirong H, Junqing W, Coffey PS, et al. Performance of the woman's condom among couples in Shanghai, China. Eur J Contracept Reprod Health Care 2012; 17:212.</a></li><li class="breakAll">http://www.asiaone.com/asia/female-condom-made-china-receives-un-and-who-approval (Accessed on September 05, 2017).</li><li><a class="nounderline abstract_t">Hou LY, Qiu HY, Zhao YZ, et al. A crossover comparison of two types of female condom. Int J Gynaecol Obstet 2010; 108:214.</a></li><li><a class="nounderline abstract_t">Wang X, Xi M, Zhang L, et al. Awareness of female condoms and failures reported with two different types in China. Int J Gynaecol Obstet 2015; 128:152.</a></li><li><a class="nounderline abstract_t">Farr G, Gabelnick H, Sturgen K, Dorflinger L. Contraceptive efficacy and acceptability of the female condom. Am J Public Health 1994; 84:1960.</a></li><li class="breakAll">Trussell J, Aiken ARA, Micks E, Guthrie K. Efficacy, safety, and personal considerations. In: Contraceptive Technology, 21st ed, Hatcher RA, Nelson AL, Trussell J, et al (Eds), Ayer Company Publishers, Inc., New York 2018.</li><li><a class="nounderline abstract_t">Bounds W, Guillebaud J, Newman GG. Female condom (Femedon). A clinical study of its use-effectiveness and patient acceptability. The British Journal of Family Planning 1992; 18:36.</a></li><li><a class="nounderline abstract_t">Trussell, J. Contraceptive efficacy of the Reality female condom. Contraception 1998; 58:147.</a></li><li><a class="nounderline abstract_t">Gallo MF, Kilbourne-Brook M, Coffey PS. A review of the effectiveness and acceptability of the female condom for dual protection. Sex Health 2012; 9:18.</a></li><li><a class="nounderline abstract_t">Vijayakumar G, Mabude Z, Smit J, et al. A review of female-condom effectiveness: patterns of use and impact on protected sex acts and STI incidence. Int J STD AIDS 2006; 17:652.</a></li><li><a class="nounderline abstract_t">Drew WL, Blair M, Miner RC, Conant M. Evaluation of the virus permeability of a new condom for women. Sex Transm Dis 1990; 17:110.</a></li><li><a class="nounderline abstract_t">Voeller B, Coulter SL, Mayhan KG. Gas, dye, and viral transport through polyurethane condoms. JAMA 1991; 266:2986.</a></li><li><a class="nounderline abstract_t">Soper DE, Shoupe D, Shangold GA, et al. Prevention of vaginal trichomoniasis by compliant use of the female condom. Sex Transm Dis 1993; 20:137.</a></li><li><a class="nounderline abstract_t">French PP, Latka M, Gollub EL, et al. Use-effectiveness of the female versus male condom in preventing sexually transmitted disease in women. Sex Transm Dis 2003; 30:433.</a></li><li><a class="nounderline abstract_t">Fontanet AL, Saba J, Chandelying V, et al. Protection against sexually transmitted diseases by granting sex workers in Thailand the choice of using the male or female condom: results from a randomized controlled trial. AIDS 1998; 12:1851.</a></li><li><a class="nounderline abstract_t">Hoke TH, Feldblum PJ, Van Damme K, et al. Temporal trends in sexually transmitted infection prevalence and condom use following introduction of the female condom to Madagascar sex workers. Int J STD AIDS 2007; 18:461.</a></li><li><a class="nounderline abstract_t">Feldblum PJ, Kuyoh MA, Bwayo JJ, et al. Female condom introduction and sexually transmitted infection prevalence: results of a community intervention trial in Kenya. AIDS 2001; 15:1037.</a></li><li><a class="nounderline abstract_t">Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64:1.</a></li><li><a class="nounderline abstract_t">Philpott A, Knerr W, Boydell V. Pleasure and prevention: when good sex is safer sex. Reprod Health Matters 2006; 14:23.</a></li><li><a class="nounderline abstract_t">Witte SS, Stefano K, Hawkins C. Can medicaid reimbursement help give female condoms a second chance in the United States? Am J Public Health 2010; 100:1835.</a></li><li><a class="nounderline abstract_t">Hoffman S, Mantell J, Exner T, Stein Z. The future of the female condom. Perspect Sex Reprod Health 2004; 36:120.</a></li><li><a class="nounderline abstract_t">Hatzell T, Feldblum PJ, Homan RK, Gmach RD. The female condom: is "just as good" good enough? Sex Transm Dis 2003; 30:440.</a></li><li class="breakAll">Peterson, K, Herman, L, Fiske, L, Marseille, E, Kahn, JG. Smarter Programming of the Female Condom: Increasing Its Impact on HIV Prevention in the Developing World. FSG Social Impact Advisors, Boston 2008.</li><li><a class="nounderline abstract_t">Renzi C, Tabet SR, Stucky JA, et al. Safety and acceptability of the Reality condom for anal sex among men who have sex with men. AIDS 2003; 17:727.</a></li><li><a class="nounderline abstract_t">Galvão LW, Oliveira LC, Díaz J, et al. Effectiveness of female and male condoms in preventing exposure to semen during vaginal intercourse: a randomized trial. Contraception 2005; 71:130.</a></li><li><a class="nounderline abstract_t">Macaluso M, Blackwell R, Jamieson DJ, et al. Efficacy of the male latex condom and of the female polyurethane condom as barriers to semen during intercourse: a randomized clinical trial. Am J Epidemiol 2007; 166:88.</a></li><li><a class="nounderline abstract_t">Chen MP, Macaluso M, Blackwell R, et al. Self-reported mechanical problems during condom use and semen exposure. Comparison of two randomized trials in the United States of America and Brazil. Sex Transm Dis 2007; 34:557.</a></li><li><a class="nounderline abstract_t">Beksinska M, Smit J, Greener R, et al. The female condom learning curve: patterns of female condom failure over 20 uses. Contraception 2015; 91:85.</a></li><li><a class="nounderline abstract_t">Joanis C, Latka M, Glover LH, Hamel S. Structural integrity of the female condom after a single use, washing, and disinfection. Contraception 2000; 62:63.</a></li><li><a class="nounderline abstract_t">Potter B, Gerofi J, Pope M, Farley T. Structural integrity of the polyurethane female condom after multiple cycles of disinfection, washing, drying and relubrication. Contraception 2003; 67:65.</a></li><li><a class="nounderline abstract_t">Pettifor AE, Rees HV, Beksinska ME, et al. In vitro assessment of the structural integrity of the female condom after multiple wash, dry, and re-lubrication cycles. Contraception 2000; 61:271.</a></li></ol></div><div id="topicVersionRevision">Topic 5471 Version 28.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Family Planning: A Global Handbook for Providers (2018 update), World Health Organization Department of Reproductive Health and Research (WHO/RHR), Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP), Knowledge for Health Project (Eds), CCP and WHO, Baltimore and Geneva 2018. p.261-270.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Center for Health and Gender Equity. Saving lives now: Female condoms and the role of US foreign aid. Takoma Park, MD, 2008.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="http://www.fc2femalecondom.com" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : fc2 Female Condom. Veru Inc. 2018. http://www.fc2femalecondom.com (Accessed on July 13, 2018).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16531174" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Short-term acceptability of the Reality polyurethane female condom and a synthetic latex prototype: a randomized crossover trial among South African women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16531173" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Performance of the Reality polyurethane female condom and a synthetic latex prototype: a randomized crossover trial among South African women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Second generation of female condom receives FDA committee approval</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25104263" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Performance and safety of the second-generation female condom (FC2) versus the Woman's, the VA worn-of-women, and the Cupid female condoms: a randomised controlled non-inferiority crossover trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23245425" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : New female condoms in the pipeline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23245425" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : New female condoms in the pipeline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26002805" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : A randomized noninferiority crossover controlled trial of the functional performance and safety of new female condoms: an evaluation of the Velvet, Cupid2, and FC2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19014792" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Comparative crossover study of the PATH Woman's Condom and the FC Female Condom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21397088" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Female condom technology: new products and regulatory issues.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22497293" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Performance of the woman's condom among couples in Shanghai, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22497293" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Performance of the woman's condom among couples in Shanghai, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19939380" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : A crossover comparison of two types of female condom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25458411" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Awareness of female condoms and failures reported with two different types in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7998637" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Contraceptive efficacy and acceptability of the female condom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7998637" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Contraceptive efficacy and acceptability of the female condom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Female condom (Femedon). A clinical study of its use-effectiveness and patient acceptability</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Contraceptive efficacy of the Reality female condom</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22348629" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : A review of the effectiveness and acceptability of the female condom for dual protection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17059633" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : A review of female-condom effectiveness: patterns of use and impact on protected sex acts and STI incidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2163113" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Evaluation of the virus permeability of a new condom for women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1820468" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Gas, dye, and viral transport through polyurethane condoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8511706" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Prevention of vaginal trichomoniasis by compliant use of the female condom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12916135" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Use-effectiveness of the female versus male condom in preventing sexually transmitted disease in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9792386" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Protection against sexually transmitted diseases by granting sex workers in Thailand the choice of using the male or female condom: results from a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17623503" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Temporal trends in sexually transmitted infection prevalence and condom use following introduction of the female condom to Madagascar sex workers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11399986" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Female condom introduction and sexually transmitted infection prevalence: results of a community intervention trial in Kenya.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26042815" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Sexually transmitted diseases treatment guidelines, 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17101419" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Pleasure and prevention: when good sex is safer sex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20724690" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Can medicaid reimbursement help give female condoms a second chance in the United States?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15306270" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The future of the female condom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12916136" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The female condom: is "just as good" good enough?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12916136" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The female condom: is "just as good" good enough?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12646796" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Safety and acceptability of the Reality condom for anal sex among men who have sex with men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15707563" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Effectiveness of female and male condoms in preventing exposure to semen during vaginal intercourse: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17420182" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Efficacy of the male latex condom and of the female polyurethane condom as barriers to semen during intercourse: a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17417133" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Self-reported mechanical problems during condom use and semen exposure. Comparison of two randomized trials in the United States of America and Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25444717" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : The female condom learning curve: patterns of female condom failure over 20 uses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11102589" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Structural integrity of the female condom after a single use, washing, and disinfection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12521661" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Structural integrity of the polyurethane female condom after multiple cycles of disinfection, washing, drying and relubrication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10899483" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : In vitro assessment of the structural integrity of the female condom after multiple wash, dry, and re-lubrication cycles.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
